Rock Creek Pharmaceuticals Announces Market Entry of Anatabloc® Unflavored as the First Brand Extension of its Anatabloc® P...
12 Avril 2012 - 9:29PM
Business Wire
Rock Creek Pharmaceuticals, Inc., a wholly owned subsidiary of
Star Scientific, Inc. (NASDAQ: CIGX), announced that Anatabloc®
Unflavored is available as an option on the shopping cart on the
Anatabloc® website at https://store.anatabloc.com/products as of
today. Anatabloc® Unflavored is a revised formulation containing
the same active dietary ingredients in the same dose as our
original Anatabloc® product. A significant number of individuals
using Anatabloc® communicated to us their interest in an Anatabloc®
product without mint flavoring; others expressed an interest in a
product that does not contain artificial sugar substitutes.
Anatabloc® Unflavored is a formulation that can be used by any
current or new users of our Anatabloc® product who wish to avoid
sweeteners and flavors. The new formulation is the same as the
original with respect to the other ingredients and can be used in
the same manner.
Anatabloc(R) Unflavored (Photo: Business
Wire)
As of today, the Anatabloc® Unflavored image appears on the main
landing page for the Anatabloc® website. Visitors to the website
will be able to purchase Anatabloc® Unflavored at a single,
one-time purchase price of $99.99 or as part of our Advantage Club
renewal program, at $79.99. Each bottle of Anatabloc® Unflavored
will contain 200 tablets.
Curtis Wright, IV, MD/MPH, Senior Vice President and Medical
Director of Rock Creek Pharmaceuticals said, “When we received the
first request for an alternative formulation, there was never any
doubt that we would try to fulfill it, since we anticipated that
various consumers would want to have the benefit of using
Anatabloc® without artificial flavors or sweeteners. We are very
pleased that our production team was able to develop a formulation
free of artificial flavors and sweeteners for those customers who
either do not care for the mint flavoring or prefer not to use
artificial sweeteners for a variety of personal reasons. Our goal
in formulating Anatabloc® is to promote health and optimum
nutrition, and removing barriers to use for any customer is always
a good thing to do. Most people prefer the original formulation,
but now Anatabloc® users have another choice.”
Jonnie R. Williams, CEO of Rock Creek’s parent company, Star
Scientific, Inc., stated, “The brand extension of Anatabloc®
Unflavored tablets at this time underscores our commitment to be
responsive to consumer demands as well as drive consumer
acceptance.”
Certain statements contained in this release constitute
forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995. Such statements include,
but are not limited to statements identified by words such as
"believes," "expects," "anticipates," "estimates," "intends,"
"plans," "targets," "projects" and similar expressions. The
statements in this release are based upon the current beliefs and
expectations of our company's management and are subject to
significant risks and uncertainties. Actual results may differ from
those set forth in the forward-looking statements. Numerous factors
could cause or contribute to such differences, including, but not
limited to, the challenges inherent in new product development
initiatives, including the continued development and market
acceptance of our nutraceutical and low-TSNA tobacco products, our
ability to license and protect our intellectual property, our
ability to raise additional capital in the future that is necessary
to maintain our business, changes in government policy and/or
regulation, including with respect to our nutraceutical and
low-TSNA tobacco products, as well as other risks discussed from
time to time in our filings with the Securities and Exchange
Commission, including, without limitation, our annual report on
Form 10-K for the fiscal year ended December 31, 2011. We undertake
no duty to update any forward-looking statement or any information
contained in this press release or in other public disclosures at
any time.
About Star Scientific
Star Scientific is a technology-oriented company with a mission
to reduce the harm associated with tobacco at every level. It is
engaged in the development of dissolvable smokeless tobacco
products that deliver fewer carcinogenic toxins, principally
through the utilization of the innovative StarCured® tobacco curing
technology. Its subsidiary, Rock Creek Pharmaceuticals, Inc., is
involved in the development of nutraceuticals as well as products
to address neurological and mood disorders. Rock Creek
Pharmaceuticals has scientific and research offices in Gloucester,
MA, and a regulatory office in Washington, DC. Star Scientific has
a Corporate and Sales Office in Glen Allen, VA, an Executive,
Scientific & Regulatory Affairs office in Bethesda, MD, and a
manufacturing facility in Chase City, VA.
Photos/Multimedia Gallery Available:
http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50237280&lang=en
Star Scientific, Inc. (MM) (NASDAQ:CIGX)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Star Scientific, Inc. (MM) (NASDAQ:CIGX)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024